###begin article-title 0
Ciliary Neurotrophic Factor Stimulates Muscle Glucose Uptake by a PI3-Kinase-Dependent Pathway That Is Impaired With Obesity
###end article-title 0
###begin title 1
OBJECTIVE
###end title 1
###begin p 2
###xml 384 388 <span type="species:ncbi:10090">mice</span>
Ciliary neurotrophic factor (CNTF) reverses muscle insulin resistance by increasing fatty acid oxidation through gp130-LIF receptor signaling to the AMP-activated protein kinase (AMPK). CNTF also increases Akt signaling in neurons and adipocytes. Because both Akt and AMPK regulate glucose uptake, we investigated muscle glucose uptake in response to CNTF signaling in lean and obese mice.
###end p 2
###begin title 3
RESEARCH DESIGN AND METHODS
###end title 3
###begin p 4
###xml 300 309 296 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 330 335 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
Mice were injected intraperitoneally with saline or CNTF, and blood glucose was monitored. The effects of CNTF on skeletal muscle glucose uptake and AMPK/Akt signaling were investigated in incubated soleus and extensor digitorum longus (EDL) muscles from muscle-specific AMPKalpha2 kinase-dead, gp130DeltaSTAT, and lean and obese ob/ob and high-fat-fed mice. The effect of C2-ceramide on glucose uptake and gp130 signaling was also examined.
###end p 4
###begin title 5
RESULTS
###end title 5
###begin p 6
###xml 608 613 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
CNTF reduced blood glucose and increased glucose uptake in isolated muscles in a time- and dose-dependent manner with maximal effects after 30 min with 100 ng/ml. CNTF increased Akt-S473 phosphorylation in soleus and EDL; however, AMPK-T172 phosphorylation was only increased in soleus. Incubation of muscles from AMPK kinase dead (KD) and wild-type littermates with the PI3-kinase inhibitor LY-294002 demonstrated that PI3-kinase, but not AMPK, was essential for CNTF-stimulated glucose uptake. CNTF-stimulated glucose uptake and Akt phosphorylation were substantially reduced in obesity (high-fat diet and ob/ob) despite normal induction of gp130/AMPK signaling-effects also observed when treating myotubes with C2-ceramide.
###end p 6
###begin title 7
CONCLUSIONS
###end title 7
###begin p 8
CNTF acutely increases muscle glucose uptake by a mechanism involving the PI3-kinase/Akt pathway that does not require AMPK. CNTF-stimulated glucose uptake is impaired in obesity-induced insulin resistance and by ceramide.
###end p 8
###begin p 9
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 389 390 389 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 390 390 390 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3"/>
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 418 419 418 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 669 670 669 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 701 701 701 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12"/>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 794 796 794 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 912 912 912 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17"/>
###xml 912 912 912 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18"/>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 902 908 <span type="species:ncbi:9606">humans</span>
Skeletal muscle glucose uptake is regulated by both intrinsic and circulating factors involving the phosphatidylinositol (PI3)-kinase/Akt and the AMP-activated protein kinase (AMPK) signaling pathways (1). The regulation of muscle glucose uptake by both pathways converges on AS160 (TBC1D4) and TBC1D1 where phosphorylation inhibits the negative regulation of GLUT4 vesicle translocation (2-4) to the plasma membrane (5,6). In insulin-resistant skeletal muscle, reduced insulin receptor substrate (IRS) and Akt activation results in reduced skeletal muscle glucose uptake (7,8). In contrast, activation of AMPK by endogenous circulating factors, including adiponectin (9,10) and interleuken (IL)-6 (11-13), and by pharmacological agents such as 5-aminoimidazole-4-carboxamide riboside (AICAR) (14,15) increases muscle glucose uptake, and this response is maintained in muscle from diabetic rodents and humans (16-19).
###end p 9
###begin p 10
###xml 155 157 155 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 432 434 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 570 572 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 869 871 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 872 874 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1168 1170 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 1231 1233 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1382 1384 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1489 1491 1471 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
We have recently shown that the ciliary neurotrophic factor (CNTF), a member of the IL-6 family, also activates muscle AMPK and increases lipid oxidation (20). CNTF elicits intracellular signaling pathways by ligand binding to the CNTF receptor alpha (CNTFRalpha), which initiates heterodimerization and activation of gp130 and leukemia inhibitory factor (LIF) receptor, the two transmembrane beta subunits of the receptor complex (21). This differs from the initial step in IL-6 signaling, which induces homodimerization of two gp130 subunits and does not involve LIF (22). Formation of the CNTFRalpha-gp130-LIF complex leads to association with isoforms of janus kinases, and these subsequently phosphorylate specific tyrosine residues on the intracellular domains, creating docking sites for Src homology-containing tyrosine phosphatase 2 (SH2)-containing proteins (23,24). Phosphorylation of Y757 of the intracellular domain of the beta subunit leads to activation of the PI3-kinase/Akt pathway. Activation of the PI3-kinase by gp130-LIF relies on association of the p85 subunit with the regulatory SH2 domain-containing adapter molecule GAB1 coordinated by SHP2 (25), and the assembling of the complex does not involve IRS-1 (26). Phosphorylation of four more distal tyrosine residues leads to activation of the signal transducer and activator of transcription (STAT) 1 and 3 (23). This distal domain is responsible for AMPK activation by an adenosine nucleotide-dependent mechanism (27). Because both AMPK and PI3 kinase/Akt signaling are enhanced by activation of the gp130-LIF receptor, our first aim was to test whether CNTF increases glucose uptake in skeletal muscle and the signaling pathway(s) invoked.
###end p 10
###begin p 11
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 291 293 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 294 296 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 328 330 321 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 361 363 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 700 702 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 703 705 692 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 905 909 <span type="species:ncbi:10090">mice</span>
The etiology of impaired muscle insulin signaling with obesity is multifactorial and appears to be related to at least two major events: chronic low-grade inflammation and intramyocellular lipid accumulation (7,28). Both events activate inhibitory IRS-1 kinases such as IkappaB kinase-beta (29,30), c-jun terminal amino kinase (28), and protein kinase C theta (31), which impair insulin signaling by inhibiting IRS-1 association with PI3-kinase subunits. Although this is believed to be a significant element in muscle insulin resistance, the sphingolipid ceramide also impairs insulin signaling by promoting protein phosphatase 2A-dependent Akt dephosphorylation, thereby inhibiting Akt activation (32,33). Thus, because gp130-LIF signaling to glucose uptake would be expected to be independent of IRS-1, our second aim was to determine whether gp130-LIF signaling toward glucose uptake is maintained in mice with obesity-induced insulin resistance. Analysis of the molecular pathways of CNTF signaling to glucose uptake may provide important insights into the function of gp130-LIF signaling and reveal the potential of a novel therapeutic target for type 2 diabetes.
###end p 11
###begin title 12
RESEARCH DESIGN AND METHODS
###end title 12
###begin title 13
Animals.
###end title 13
###begin p 14
###xml 10 15 10 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 54 63 50 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 305 307 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 535 537 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 538 540 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 567 576 532 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 696 698 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 153 168 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 577 581 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">Mice</span>
C57Bl6/J, ob/ob, AMPKalpha2 kinase-dead (KD) and gp130DeltaSTAT mice aged 8 to 18 weeks with corresponding littermate controls were used in experiments. Transgenic mice overexpressing a KD form of the AMPKalpha2 protein under control of the muscle creatine kinase promoter have been described previously (34). Briefly, the KD mutation was generated by Lys45Arg mutagenesis to encode a KD alpha2 protein that displaces all detectable endogenous alpha2 and 50-70% of endogenous alpha1 protein from alphabetagamma heterotrimer complexes (34,35). The knockin mutant gp130DeltaSTAT mice express a COOH-terminal truncation mutation of gp130 that prevents activation of STAT1/3 as described previously (36). This mutation has a deletion of the distal intracellular domain responsible for AMPK and STAT activation. All mice were kept at a 12:12 h light:dark cycle at 20-21degreesC and provided ad libitum access to food and water. Mice were maintained on a standard rodent chow diet/low-fat diet (5% calories fat; Harlan Teklad) except in high-fat diet (HFD) experiments, in which the diet was composed of 45% calories from fat (SF04-027; Specialty Feeds). All procedures were approved by the St. Vincent's Hospital Animal Ethics Committee.
###end p 14
###begin title 15
CNTF tolerance test.
###end title 15
###begin p 16
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
C57Bl6/J mice were fasted for 6 h before being injected with either saline or 0.3 mg/kg CNTF, a concentration of CNTF that activates AMPK and induces weight loss without eliciting an inflammatory response (20). Blood glucose was monitored over 150 min.
###end p 16
###begin title 17
Muscle incubations.
###end title 17
###begin p 18
###xml 184 186 184 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 390 391 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 447 449 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 955 957 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
Soleus (oxidative and glycolytic fibers) and extensor digitorum longus (EDL; primarily glycolytic fibers) muscles were dissected from anesthetized mice (6 mg of pentobarbital per 100 g-1 body weight) and transferred to incubation flasks containing 2 ml of essential buffer (Krebs-Henseleit buffer, pH 7.4, with 2 mmol/l pyruvate, 8 mmol/l mannitol, and 0.1% BSA), gassed with 95% O2 + 5% CO2, and maintained at 30degreesC as previously described (15). For all experiments, muscles were preincubated for 15 min in this buffer before it was replaced with buffer containing AICAR (2 mmol/l for 40 min; Toronto Research Chemicals Inc, Ontario, Canada), CNTF (at concentrations and durations indicated above, Axokine; Regeneron Pharmaceuticals Inc, New York), or insulin (30 nmol/l [additivity study] or 2.8 nmol/l [HFD study] for 40 min, Actrapid; Novo Nordisk, Bagsvaerd, Denmark). In separate experiments, muscles were incubated in LY-294002 hydrochloride (37) (60 nmol/l for 30 min; Sigma-Aldrich Corp, St. Louis, MO) before treatment with CNTF or insulin as described.
###end p 18
###begin p 19
###xml 8 9 8 9 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 164 166 163 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 173 174 172 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 183 184 182 183 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 211 212 210 211 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 238 240 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
2-deoxy-d-glucose (2DG) uptake was measured over 10 min by replacing existing incubation buffer with the buffer described above but with the addition of 0.5 muCi/ml-12-[2,6-3H]-deoxy-d-glucose, 1 mmol/l 2-deoxy-d-glucose, and 0.2 muCi [1-14C]-mannitol/ml. After preparing muscles as described below, radioactivity was measured in muscle lysates by liquid scintillation counting (Tri-Carb 2000; Packard Instrument Co).
###end p 19
###begin title 20
Muscle lysate preparation.
###end title 20
###begin p 21
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
Muscles were homogenized in ice-cold buffer (50 mmol/l Hepes, pH 7.4, 150 mmol/l NaCl, 10 mmol/l NaF, 1 mmol/l sodium pyrophosphate, 0.5 mmol/l EDTA, 250 mmol/l sucrose, 1 mmol/l dithiothreitol, 1% TritonX-100, 1 mmol/l Na3VO4, and one Roche protease inhibitor tablet per 50 ml buffer) using an electrical homogenizer. Lysates were prepared as previously described (38) and stored at -80degreesC until analysis. Protein content in lysates was measured by the bicinchoninic acid method (Pierce).
###end p 21
###begin title 22
Immunoblotting.
###end title 22
###begin p 23
###xml 266 268 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 385 396 <span type="species:ncbi:3704">horseradish</span>
Expression or phosphorylation of investigated proteins was determined in muscle lysates by SDS-PAGE and immunoblotting using the following primary antibodies: pan-alphaAMPK, phospho-AMPK T172, and phospho-acetyl CoA carboxylase (ACC) S222 (as previously described [(39)]), STAT3, phospho-STAT3 Y705, Akt, and phospho-Akt S473 (Cell Signaling Technology Inc). Secondary antibodies were horseradish-conjugated protein G (Bio-Rad Laboratories, Richmond, CA). Bands were visualized using an enhanced chemoluminescence system and quantified using ImageQuant TL 05 software (Amersham Biosciences, U.K.). Values obtained using phospho-specific antibodies are expressed as the ratio to the total content of the protein measured after stripping the membrane and reprobing.
###end p 23
###begin title 24
AMPK activity.
###end title 24
###begin p 25
###xml 175 177 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 92 98 <span type="species:ncbi:9986">rabbit</span>
AMPKalpha1 and -alpha2 activities were measured from 100 mug of muscle lysate protein using rabbit polyclonal AMPK antibodies for immunoprecipitation as previously described (40).
###end p 25
###begin title 26
Muscle lipids.
###end title 26
###begin p 27
###xml 361 363 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
Lipids were extracted from freeze-dried powdered gastrocnemius muscle tissues using chloroform:methanol:PBS (1:2:0.8) and 0.2% SDS. Triacylglycerol were saponified in an ethanol-KOH solution at 60degreesC, and glycerol content was measured fluorometrically. Diacylglycerols and ceramides were extracted and quantified according to the methods of Preiss et al. (41).
###end p 27
###begin title 28
Muscle cell studies.
###end title 28
###begin p 29
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
Muscle cells were differentiated and serum starved overnight. The next morning, 20 nmol/l C2-dihydroceramide (Toronto Research Chemicals Inc, Ontario, Canada) was added for 6 h before cells were treated for 20 min with either CNTF (10 ng/ml) or insulin (10 nmol/l) before collecting protein lysates or measuring 2DG uptake as previously described (20). C2C12 cell were used for signaling experiments and L6 muscle cells for 2DG uptake because of the limited capacity of C2C12 to increase glucose uptake in response to stimuli.
###end p 29
###begin p 30
###xml 95 96 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 266 267 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data are expressed as means +/- SE. Statistical evaluations were performed by either Student's t test or two-way ANOVA using the Student-Newman-Keuls method as a post hoc test when appropriate. Differences between groups were considered statistically significant if P < 0.05.
###end p 30
###begin title 31
RESULTS
###end title 31
###begin title 32
In vivo effects of ciliary neurotrophic factor on blood glucose.
###end title 32
###begin p 33
###xml 217 223 217 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 304 310 304 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">mice</span>
Injection of mice with CNTF was associated with a reduction in blood glucose after 40 min compared with saline-injected controls. Blood glucose remained reduced in the CNTF group throughout the remainder of the test (Fig. 1A). The AUC was 20% lower in CNTF-treated mice than in saline-injected controls (Fig. 1B).
###end p 33
###begin p 34
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
In vivo effects of CNTF on blood glucose. A: CNTF tolerance test. Change in blood glucose over time. B: AUC. Animals were injected with either CNTF (0.3 mg/kg) or saline, and changes in tail blood glucose were monitored over 150 min. n = 10. Data are means +/- SEM. *Significantly different from saline.
###end p 34
###begin title 35
Muscle glucose uptake: ciliary neurotrophic factor dose response.
###end title 35
###begin p 36
###xml 510 516 510 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 651 657 651 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 663 664 663 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 751 753 751 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1029 1035 1029 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1035 1036 1035 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 1194 1200 1194 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 1200 1201 1200 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
The effects of CNTF to reduce blood glucose in vivo may have been mediated by the suppression of hepatic glucose production or increased glucose uptake into adipose tissue and skeletal muscle. Therefore, to directly test the effects of CNTF on skeletal muscle glucose uptake, we incubated isolated muscles with CNTF at concentrations ranging from 2 to 500 ng/ml. CNTF increased muscle glucose uptake over 30 min in a dose-dependent manner with a significant increase at 2 ng/ml in both soleus and EDL muscles (Fig. 2A-B). Glucose uptake was elevated with increasing CNTF concentrations up to 100 ng/ml with no further increases observed at 500 ng/ml (Fig. 2A and B), consistent with dose-dependent effects on fatty acid oxidation observed previously (20). We next investigated if the effect of CNTF on glucose uptake was additive to the effects of insulin and AICAR. In soleus, CNTF, insulin, and AICAR independently increased glucose uptake to a similar degree, and combining AICAR and insulin with CNTF had an additive effect (Fig. 2C). In EDL, insulin and AICAR increased glucose uptake more strongly than CNTF and no further increase was observed when combining these treatments with CNTF (Fig. 2D).
###end p 36
###begin p 37
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 343 344 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 349 350 349 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Dose-dependent effect of CNTF on 2-deoxyglucose (2DG) glucose uptake and additive effects of CNTF on AICAR and insulin stimulated glucose uptake. A and B: Muscles were either incubated with vehicle (BAS) condition or stimulated with CNTF at indicated concentrations for 30 min; n = 8. *Significantly different from basal condition (P < 0.05). C and D: Muscles were incubated with CNTF (100 ng/ml), insulin (30 nmol/l), AICAR (2 mmol/l), or indicated combinations, and changes in 2DG uptake are expressed as fold increases over basal. n = 7-8. Data are means +/- SEM. *Significantly different from CNTF in the same muscle type.
###end p 37
###begin title 38
Time course of CNTF-stimulated muscle glucose uptake and signaling.
###end title 38
###begin p 39
###xml 120 126 120 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 460 466 460 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 466 467 466 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 574 580 574 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 699 700 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 710 716 707 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 716 717 713 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 780 786 774 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 786 789 780 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;D</italic>
###xml 861 863 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
CNTF increased glucose uptake in soleus and EDL after 30 min-an effect that diminished thereafter in both muscle types (Fig. 3A). CNTF has been reported to increase the activity/phosphorylation of AMPK in muscle (20) and Akt in neurons (42), and because both kinases regulate muscle glucose uptake, we examined their activating phosphorylation. CNTF increased Akt S473-P nearly 200% in soleus and 450% in EDL muscle, and these effects diminished after 90 min (Fig. 3B). AMPK T172-P was increased 90% in the soleus with CNTF after 30 min, and this was maintained for 60 min (Fig. 3C). Although CNTF induced an apparent rise in ACCbeta S218-P in soleus, this did not achieve statistical significance (P = 0.09) (Fig. 3D). CNTF had no detectable effect on AMPK- or ACCbeta-P in EDL (Fig. 3C-D), which is consistent with previous observations in glycolytic muscle (20).
###end p 39
###begin p 40
###xml 148 149 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 281 282 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 441 442 434 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 578 579 567 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 713 714 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
Time-dependent effect of CNTF on 2-deoxyglucose (2DG) uptake, Akt S473, alphaAMPK T172, and ACCbeta S218 phosphorylation in incubated mouse muscle. A: 2DG uptake in incubated soleus and EDL at basal conditions and after incubation with 100 ng/ml CNTF at indicated periods of time. B: Akt S473 phosphorylation in lysates from incubated soleus and EDL at basal conditions and after incubation with 100 ng/ml CNTF at indicated periods of time. C: alphaAMPK T172 phosphorylation in lysates from incubated soleus and EDL at basal conditions and after incubation with 100 ng/ml CNTF. D: ACCbeta S218 phosphorylation in lysates from incubated soleus and EDL at basal conditions and after incubation with 100 ng/ml CNTF. n = 8. Data are means +/- SEM. *Significantly different from basal condition.
###end p 40
###begin title 41
Effects of PI3-kinase inhibition and ablated AMPK activity on CNTF actions.
###end title 41
###begin p 42
###xml 508 514 508 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 514 515 514 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 492 497 <span type="species:ncbi:10090">mouse</span>
We next examined the relative importance of AMPK and PI3K/Akt signaling for CNTF-mediated glucose uptake. Muscles from wild-type and AMPK KD mice were preincubated with or without the PI3-kinase inhibitor, LY-294002, followed by stimulation with CNTF. Glucose uptake was increased to a similar degree with CNTF in wild-type and AMPK KD muscles, indicating that this response was AMPK independent. CNTF-stimulated glucose uptake was abolished by LY-294002 in both muscle types irrespective of mouse genotype (Fig. 4A), which is consistent with PI3-kinase/Akt signaling being essential for this response.
###end p 42
###begin p 43
###xml 249 250 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 363 373 363 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 384 395 384 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 590 600 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</italic>
###xml 611 622 607 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</italic>
###xml 693 694 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 838 839 834 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 969 970 965 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 193 198 <span type="species:ncbi:10090">mouse</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
Effect of impaired AMPK signaling and the PI3-kinase inhibitor LY-294002 on CNTF-stimulated 2-deoxyglucose (2DG) uptake, AMPK activity, and Akt S473 and STAT3 Y705 phosphorylation in incubated mouse muscle from wild-type (WT) and AMPK KD (Tg) mice. A: 2DG uptake at basal and after incubation with 100 ng/ml CNTF with or without 60 nmol/l of LY-294002 in soleus (left panel) and EDL (right panel) muscle. In addition, incubation of wild-type muscle at basal with 2.8 nmol/l insulin (ins) with and without LY-294002. B: alpha-Isoform-specific AMPK activity in lysates from incubated soleus (left panel) and EDL (right panel) muscle at basal and after incubation with 100 ng/ml CNTF for 30 min. C: STAT3 Y705 phosphorylation in lysates from incubated EDL muscle at basal and after incubation with 100 ng/ml CNTF with and without LY-294002. D: Akt phosphorylation in lysates from incubated EDL at basal and after incubation with 100 ng/ml CNTF with and without LY-294002. n = 8. Data are means +/- SEM. *Significantly different from basal condition. daggerSignificantly different from CNTF or insulin stimulated. Significantly different from WT.
###end p 43
###begin p 44
###xml 178 184 174 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 184 185 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 379 381 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 552 558 532 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 558 559 538 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 610 616 590 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 616 617 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 705 711 685 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 711 712 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
We next measured alpha-isoform-specific AMPK activity to verify that CNTF had activated AMPK signaling in wild-type mice and that the activation was impaired in AMPK KD muscles (Fig. 4B). As anticipated, overexpression of the AMPK KD construct lowered basal AMPK activity of both alpha-AMPK isoforms in both muscle types, with the most pronounced effect on alpha2-AMPK activity (34). In wild-type soleus, CNTF increased alpha1-AMPK activity by 180% and alpha2-AMPK activity by 35%, whereas CNTF had no effect on either AMPK isoform in AMPK KD muscles (Fig. 4B). CNTF did not increase AMPK activity in the EDL (Fig. 4B), which is consistent with CNTF not increasing AMPK phosphorylation in the EDL muscle (Fig. 3C).
###end p 44
###begin p 45
###xml 442 448 442 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 448 449 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 609 615 609 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 615 616 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
Lastly, to establish whether inhibition of PI3-kinase or AMPK signaling altered proximal CNTF signaling through the gp130-LIF receptor complex, we examined STAT3 Y705-P in the EDL muscle of wild-type and AMPK KD mice in the absence or presence of LY-294002. Incubation with CNTF increased STAT3 Y705-P by 140% in wild-type muscle, and importantly, the increase was unaffected in AMPK-KD muscles and unaffected by coincubation with LY-294002 (Fig. 4C). We also verified that increases in Akt-P with CNTF were not affected by overexpression of the AMPK KD construct and that LY 294002 inhibited Akt activation (Fig. 4D). Similar findings were observed in the soleus muscle (data not shown).
###end p 45
###begin title 46
###xml 39 48 39 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
CNTF-stimulated glucose uptake in gp130DeltaSTAT muscles.
###end title 46
###begin p 47
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 480 489 480 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 846 855 842 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 877 883 869 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 883 884 875 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 996 1005 988 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 1027 1033 1015 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1033 1034 1021 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 871 875 <span type="species:ncbi:10090">mice</span>
Signaling from the gp130-LIF receptor complex activates two distinct intracellular signaling pathways. The first depends on phosphorylation of four tyrosine residues (Y765, Y812, Y904, and Y914) on the distal cytoplasmic tail of gp130, which is required and sufficient for activating STAT1/3 (23) and AMPK (20). The second arm requires phosphorylation of the more proximal Y757 residue in gp130, which induces ERK and PI3-kinase/Akt signaling (23). We incubated muscles from gp130DeltaSTAT mice, which have a deletion of the cytosolic distal portion of the gp130 receptor required for induction of STAT1/3 and AMPK signaling but retain the Y757 residue that is required for activation of Erk and PI3-kinase/Akt signaling. Incubation with CNTF increased glucose uptake in soleus and EDL of wild-type mice, and this increase was maintained in gp130DeltaSTAT knockin mutant mice (Fig. 5A). CNTF increased Akt S473-P in both genotypes, whereas STAT3 Y705-P was increased in wild-type but not in gp130DeltaSTAT muscles as expected (Fig. 5B). Thus, CNTF increased glucose uptake normally despite impaired gp130 signaling and activation of AMPK.
###end p 47
###begin p 48
###xml 42 43 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 163 172 163 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;STAT</sup>
###xml 264 265 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 173 177 <span type="species:ncbi:10090">mice</span>
CNTF-induced 2-deoxyglucose (2DG) uptake (A) and STAT3 Y705 and Akt S473 phosphorylation (B) in incubated soleus and EDL mouse muscle from wild-type (WT) and gp130DeltaSTAT mice. (Muscles were either incubated at basal condition or with 100 ng/ml CNTF for 30 min [n = 8].) Data are means +/- SEM. *Significantly different from basal condition.
###end p 48
###begin title 49
Effects of obesity on CNTF-stimulated muscle glucose uptake and signaling.
###end title 49
###begin p 50
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 662 667 638 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 738 744 712 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob,</italic>
###xml 799 805 769 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob,</italic>
###xml 1039 1045 995 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1045 1046 1001 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1141 1146 1097 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1206 1211 1162 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 1218 1224 1174 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 1224 1225 1180 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 668 672 <span type="species:ncbi:10090">mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 1023 1027 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
It is well established that obesity is associated with impaired insulin sensitivity in skeletal muscle, and impaired activation of IRS-1 has been attributed a primary role (28,43). Because CNTF stimulates glucose uptake downstream of IRS-1, we tested whether CNTF-stimulated glucose uptake is maintained in muscles from mice fed a HFD for 12 weeks and obese mice deficient in leptin (ob/ob). As dictated by design, the high-fat feeding increased body weight by approximately20% (chow, 28.4 +/- 0.5 g; HFD, 34.0 +/- 0.7 g), fasting insulin levels (836 +/- 76 pg/ml to 1,670 +/- 377 pg/ml), and the AUC during a GTT (chow, 539 +/- 23; HFD, 870 +/- 94). Similarly, ob/ob mice had dramatically increased body mass (wild-type, 29.6 +/- 0.7 g; ob/ob, 57.3 +/- 2.8 g) and AUC during a GTT (WT, 574 +/- 26; ob/ob, 1,347 +/- 98). CNTF increased glucose uptake by 80 to 100% in the soleus and EDL in chow-fed mice, whereas CNTF-stimulated glucose uptake was completely blunted in the soleus and reduced by approximately50% in EDL of mice fed a HFD (Fig. 6A). Similarly, CNTF increased muscle glucose uptake in both muscle types of lean littermates of ob/ob mice; however, this increase was abolished in muscles from ob/ob mice (Fig. 6B).
###end p 50
###begin p 51
###xml 66 67 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 85 86 85 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 134 135 134 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 241 242 241 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 370 371 368 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 380 381 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
CNTF-stimulated 2-deoxyglucose (2DG) uptake in high-fat diet-fed (A) and ob/ob mice (B), STAT3 Y705 (C), Akt S473 (D), and AMPK T172 (E) phosphorylation in soleus and EDL mouse muscle from mice fed standard chow (Ch) or an HFD for 12 weeks; n = 8-10 for HFD experiment and 7-8 for ob/ob experiment. Data are means +/- SEM. *Significantly different from basal condition (P < 0.05, P < 0.001). daggerSignificantly different from CNTF-stimulated chow-fed/control mice.
###end p 51
###begin p 52
###xml 167 173 167 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 173 174 173 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 421 427 421 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 427 428 427 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 495 501 495 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Fig. 6</xref>
###xml 501 502 501 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
We then examined the mechanism by which obesity inhibited CNTF-stimulated glucose uptake. CNTF increased STAT3 Y705-P in skeletal muscle of chow- and HFD-fed animals (Fig. 6C), indicating no impairment of CNTF action at the receptor level. CNTF-induced Akt S473-P was increased by 4- and 19-fold in soleus and EDL of chow-fed mice, respectively, and this increase was markedly impaired with obesity in both muscle types (Fig. 6D). In contrast, AMPK T172-P in soleus was also unaffected by diet (Fig. 6E).
###end p 52
###begin title 53
Muscle lipids and CNTF signaling.
###end title 53
###begin p 54
###xml 201 207 165 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 207 208 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 305 307 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 595 601 559 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 601 602 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 801 807 753 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 807 808 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 878 884 830 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 884 885 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 915 916 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1002 1008 954 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Fig. 7</xref>
###xml 1008 1009 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</italic>
High-fat feeding increased muscle contents of triacylglycerol, diacylglycerol, and ceramide by approximately100%, approximately50%, and approximately50%, respectively, compared with chow-fed controls (Fig. 7A). Because ceramides have been shown to directly inhibit insulin-stimulated Akt phosphorylation (33), we tested whether exposure of cultured myotubes to a short-chain ceramide analog also impaired CNTF-stimulated glucose uptake and Akt phosphorylation. Consistent with our findings in obese skeletal muscle, myotubes treated with C2-ceramide had impaired CNTF-stimulated glucose uptake (Fig. 7B). Reductions in glucose uptake were not the result of inhibition of the gp130-LIF receptor complex because CNTF increased STAT3-P by approximately350% in both vehicle and C2-ceramide-treated cells (Fig. 7C). However, C2-ceramide reduced basal and CNTF-stimulated Akt S473-P (Fig. 7D). AMPK T172-P was increased (P < 0.05) by 60% with CNTF, and this increase was unaffected by C2-ceramide treatment (Fig. 7E).
###end p 54
###begin p 55
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 271 272 271 272 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sc>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C&#8211;E</italic>
###xml 550 551 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 560 561 560 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Muscle lipids in gastrocnemius muscle from mice fed standard chow or an HFD and STAT3 Y705, Akt S473, and AMPK T172 phosphorylation in C2C12 myocytes. A: Muscle content of triacylglycerol (TAG), diacylglycerol (DAG), and ceramides. B: CNTF and insulin-stimulated 2-deoxy-d-glucose uptake in L6 myotubes treated with either C2-ceramide or vehicle for 6 h. C-E: Phosphorylation of CNTF-activated signaling molecules in C2C12 myotubes treated with C2-ceramide for 6 h or CNTF for 30 min or in combination. *Significantly different from basal condition (P < 0.05, P < 0.001).
###end p 55
###begin title 56
DISCUSSION
###end title 56
###begin p 57
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
CNTF can regulate metabolic and growth signaling pathways in several tissue types. The present study shows that CNTF regulates glucose uptake and delineates the proximal signaling events mediating this response. We show that acute exposure of CNTF reduces blood glucose in vivo and increases glucose uptake in soleus and EDL muscle in vitro through the PI3-kinase/Akt signaling pathway. It was expected that AMPK would also exert a role in this process, but we found that AMPK was not required for CNTF to stimulate glucose uptake. Skeletal muscle is the most important tissue for insulin-stimulated glucose disposal (44), and skeletal muscle insulin resistance is a major defect in most obese phenotypes. Accordingly, we investigated whether CNTF-stimulated glucose uptake was maintained in muscle from obese, insulin-resistant mice. The rationale for these studies was to establish whether gp130-LIF signaling could constitute an alternative pathway to substitute for insufficient insulin signaling to skeletal muscle glucose uptake. However, obesity was associated with impaired CNTF-stimulated glucose uptake, which, at least in part, may have been attributed to increased muscle lipids and impaired PI3-kinase/Akt signaling with CNTF.
###end p 57
###begin p 58
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">49</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 899 901 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 575 579 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 1159 1165 <span type="species:ncbi:9606">humans</span>
CNTF is a peptide hormone of the IL-6 family, which is highly expressed in peripheral nerves and other tissues (24,45,46). CNTF levels are low in serum of healthy individual as a result of the absence of an exocytosis targeting sequence (47,48). Recent reports have shown significant promise for the use of CNTF as an antiobesity therapeutic because it suppresses food intake acutely (49) and induces hypothalamic neurogenesis (50), leading to a new set point in body mass. CNTF also has direct antidiabetic effects in peripheral tissues. Chronic treatment of obese diabetic mice with CNTF increases metabolic rate (51) and reduces liver steatosis by enhancing fat oxidation and reducing synthesis of complex lipids (52). We have recently shown that chronic CNTF treatment of obese diabetic mice reverses obesity-induced insulin resistance by activating AMPK and reducing muscle lipid accumulation (20). In line with this study, CNTF acutely prevents muscle insulin resistance in response to a 2-h lipid infusion by preventing lipid accumulation (27). The clinical efficacy and safety of CNTF as a possible therapeutic for obesity is supported by findings in humans demonstrating weight loss and improved glycemic control (53).
###end p 58
###begin p 59
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</italic>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 654 655 654 655 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</italic>
###xml 747 748 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</italic>
###xml 842 843 838 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</italic>
###xml 1001 1002 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</italic>
###xml 1812 1814 1792 1794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1670 1674 <span type="species:ncbi:10090">mice</span>
Because we previously showed that CNTF activates AMPK in muscle (20) and AMPK is well known to increase glucose uptake in skeletal muscle (15,54,55), we expected AMPK rather than PI3-kinase/Akt signaling to be required for CNTF-stimulated glucose uptake. However, multiple lines of evidence indicate that CNTF signaling to glucose uptake may be mediated by a PI3-kinase/Akt-dependent signaling pathway: 1) the kinetics in Akt S473 phosphorylation correlated with increases in glucose uptake in both soleus and EDL muscles; 2) incubation with the PI3-kinase inhibitor, LY-294002, completely blocked CNTF-stimulated Akt phosphorylation and glucose uptake; 3) CNTF increased glucose uptake was not impaired in muscles overexpressing a KD AMPKalpha2; 4) AMPK was not activated by CNTF in the EDL muscle despite a 100% increase in glucose uptake; 5) a knockin mutation of a truncated gp130 receptor, which impairs gp130 signaling toward STAT3 and AMPK, had no effect on CNTF-stimulated glucose uptake; and 6) obesity induced by an HFD or treatment of cells with C2-ceramide impaired CNTF stimulated glucose uptake and was associated with blunted Akt but not AMPK phosphorylation. However, our findings demonstrating that CNTF-stimulated glucose uptake was additive to a maximal dose of insulin in Soleus, but not EDL muscle suggest that under some conditions, AMPK activation may also play a role in the stimulation of glucose uptake in Soleus, albeit to a lesser extent than originally anticipated. A possible explanation for the limited role of AMPK in CNTF-stimulated glucose uptake is that CNTF predominantly activated the alpha1-AMPK isoform. Studies in AMPKalpha2-null mice have shown that AMPKalpha2, but not alpha1 is required for the regulation of muscle glucose uptake in response to stimuli such as AICAR (15), possibly explaining why CNTF activation of AMPK is not required to increase glucose transport.
###end p 59
###begin p 60
###xml 285 290 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ob/ob</italic>
###xml 748 750 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 863 865 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1200 1202 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1225 1227 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1240 1242 1225 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1815 1817 1800 1802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 945 949 <span type="species:ncbi:10090">mice</span>
###xml 1233 1238 <span type="species:ncbi:9606">human</span>
###xml 1801 1806 <span type="species:ncbi:10090">mouse</span>
Because we found CNTF to increase muscle glucose uptake, it was of interest to test the effects of CNTF in insulin-resistant muscle from obese mice. We found that the efficacy of CNTF to regulate glucose uptake was reduced by approximately50% or more in muscles from obese HFD-fed and ob/ob mice. CNTF resistance with obesity seems not to be the result of impaired activation of the gp130-LIF receptor complex because CNTF-induced phosphorylation of AMPK and STAT3 were normal in obese muscle. In contrast, CNTF-stimulated phosphorylation of Akt was suppressed in obese muscles and was associated with muscle DAG and ceramide accumulation. Ceramides downregulate Akt phosphorylation and membrane translocation by activating protein phosphatase 2A (56). Ceramides also increase the activity of protein kinase C zeta, leading to inhibitory Akt S34 phosphorylation (57). In addition to the finding that ceramides were elevated in muscle from obese mice, our studies in myotubes showed that the C2-ceramide not only reduced basal Akt phosphorylation but also completely prevented CNTF-induced Akt phosphorylation and CNTF-stimulated glucose uptake. These results agree with previous studies in myotubes (33) and isolated rodent (32) and human (58) skeletal muscle demonstrating impaired insulin-stimulated Akt activation and glucose uptake when ceramides are elevated. In the present studies, DAG and a reduction in PI-3 kinase activity may have also contributed to the reduced CNTF activation of Akt in muscles from obese animals. Importantly, the finding that neither the C2-ceramide nor obesity altered CNTF-induced STAT3 and AMPK phosphorylation is consistent with our previous findings that CNTF activation of AMPK and lipid metabolism is maintained in skeletal muscles from obese, insulin-resistant mouse models (20). Thus, although the signaling arm of CNTF to glucose uptake is compromised with obesity, the activation of AMPK and lipid oxidation is preserved.
###end p 60
###begin p 61
###xml 258 262 <span type="species:ncbi:10090">mice</span>
In summary, our data show that CNTF-stimulated glucose uptake is associated with activation of the PI3-kinase/Akt signaling pathway. Furthermore, CNTF-stimulated Akt S473 phosphorylation and glucose uptake is impaired in muscles from obese insulin-resistant mice despite the maintenance of STAT3 and AMPK signaling. This mechanism may, in part, be attributable to ceramide accumulation with obesity, which in turn impairs CNTF signaling to the PI3-kinase/Akt signaling arm of the gp130 receptor. Because CNTF-induced activation of AMPK was maintained in obesity, CNTF or CNTF analogs provide the bases for a viable therapeutic to prevent muscle lipid accumulation and to restore insulin sensitivity in obesity.
###end p 61
###begin p 62
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 62
###begin title 63
Acknowledgments
###end title 63
###begin p 64
This research was supported by grants from the National Health and Medical Research Council, Australia (G.R.S., M.J.W., and B.E.K.) and the National Institutes of Health (NIH), U.S. (M.J.B.; R01-DK56886). S.B.J. was supported by a Danish Research Council of Health and Diseases postdoctoral fellowship. M.J.W. is an R. Douglas Wright Fellow, and G.R.S. is a National Health and Medical Research Council of Australia Research Fellow and a Canadian Research Chair in Metabolism, Obesity and Type 2 Diabetes. B.E.K. is an Australian Research Council Federation Fellow.
###end p 64
###begin p 65
No potential conflicts of interest relevant to this article were reported.
###end p 65
###begin title 66
REFERENCES
###end title 66
###begin article-title 67
Skeletal muscle glucose uptake during exercise: how is it regulated?
###end article-title 67
###begin article-title 68
###xml 65 68 <span type="species:ncbi:10116">rat</span>
Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity.
###end article-title 68
###begin article-title 69
AMPK-mediated AS160 phosphorylation in skeletal muscle is dependent on AMPK catalytic and regulatory subunits.
###end article-title 69
###begin article-title 70
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle.
###end article-title 70
###begin article-title 71
###xml 55 60 <span type="species:ncbi:9606">human</span>
Immunolocalization of glucose transporter GLUT4 within human skeletal muscle.
###end article-title 71
###begin article-title 72
Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation.
###end article-title 72
###begin article-title 73
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle.
###end article-title 73
###begin article-title 74
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).
###end article-title 74
###begin article-title 75
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.
###end article-title 75
###begin article-title 76
Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation.
###end article-title 76
###begin article-title 77
###xml 63 69 <span type="species:ncbi:9606">humans</span>
Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.
###end article-title 77
###begin article-title 78
IL-6 increases muscle insulin sensitivity only at superphysiological levels.
###end article-title 78
###begin article-title 79
###xml 63 68 <span type="species:ncbi:9606">human</span>
Interleukin-6 directly increases glucose metabolism in resting human skeletal muscle.
###end article-title 79
###begin article-title 80
Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport.
###end article-title 80
###begin article-title 81
Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside but not contraction-induced glucose uptake in skeletal muscle.
###end article-title 81
###begin article-title 82
5-Amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes.
###end article-title 82
###begin article-title 83
###xml 151 155 <span type="species:ncbi:10090">mice</span>
5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice.
###end article-title 83
###begin article-title 84
###xml 54 59 <span type="species:ncbi:9606">human</span>
AMP-activated protein kinase is not down-regulated in human skeletal muscle of obese females.
###end article-title 84
###begin article-title 85
###xml 138 142 <span type="species:ncbi:10116">rats</span>
AMP-Activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
###end article-title 85
###begin article-title 86
CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK.
###end article-title 86
###begin article-title 87
LIFR beta and gp130 as heterodimerizing signal transducers of the tripartite CNTF receptor.
###end article-title 87
###begin article-title 88
IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase.
###end article-title 88
###begin article-title 89
Acquiring signalling specificity from the cytokine receptor gp130.
###end article-title 89
###begin article-title 90
gp130 receptor ligands as potential therapeutic targets for obesity.
###end article-title 90
###begin article-title 91
Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase.
###end article-title 91
###begin article-title 92
Hepatocyte growth factor induces glucose uptake in 3T3-L1 adipocytes through A Gab1/phosphatidylinositol 3-kinase/Glut4 pathway.
###end article-title 92
###begin article-title 93
Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues.
###end article-title 93
###begin article-title 94
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.
###end article-title 94
###begin article-title 95
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta.
###end article-title 95
###begin article-title 96
IKK-beta links inflammation to obesity-induced insulin resistance.
###end article-title 96
###begin article-title 97
###xml 19 23 <span type="species:ncbi:10090">mice</span>
PKC-theta knockout mice are protected from fat-induced insulin resistance.
###end article-title 97
###begin article-title 98
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.
###end article-title 98
###begin article-title 99
Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate.
###end article-title 99
###begin article-title 100
A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport I skeletal muscle.
###end article-title 100
###begin article-title 101
Caffeine-induced Ca2+ release increases AMPK-dependent glucose uptake in rodent soleus muscle.
###end article-title 101
###begin article-title 102
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.
###end article-title 102
###begin article-title 103
Differential regulation of MAP kinase by contraction and insulin in skeletal muscle: metabolic implications.
###end article-title 103
###begin article-title 104
The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.
###end article-title 104
###begin article-title 105
AMP-activated protein kinase phosphorylation of endothelial NO synthase.
###end article-title 105
###begin article-title 106
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.
###end article-title 106
###begin article-title 107
###xml 122 125 <span type="species:ncbi:10116">rat</span>
Quantitative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells.
###end article-title 107
###begin article-title 108
Role of STAT3 and PI 3-kinase/Akt in mediating the survival actions of cytokines on sensory neurons.
###end article-title 108
###begin article-title 109
Etiology of insulin resistance.
###end article-title 109
###begin article-title 110
Rates and tissue sites of non-ins.
###end article-title 110
###begin article-title 111
Preparation and biological properties of native and recombinant ciliary neurotrophic factor.
###end article-title 111
###begin article-title 112
The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor.
###end article-title 112
###begin article-title 113
###xml 54 61 <span type="species:ncbi:9606">persons</span>
###xml 74 95 <span type="species:ncbi:5833">Plasmodium falciparum</span>
Plasma levels of the interleukin-6 cytokine family in persons with severe Plasmodium falciparum malaria.
###end article-title 113
###begin article-title 114
###xml 59 62 <span type="species:ncbi:10116">rat</span>
Molecular cloning, expression and regional distribution of rat ciliary neurotrophic factor.
###end article-title 114
###begin article-title 115
###xml 99 103 <span type="species:ncbi:10090">mice</span>
Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice.
###end article-title 115
###begin article-title 116
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Neurogenesis in the hypothalamus of adult mice: potential role in energy balance.
###end article-title 116
###begin article-title 117
###xml 148 152 <span type="species:ncbi:10090">mice</span>
Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice.
###end article-title 117
###begin article-title 118
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice.
###end article-title 118
###begin article-title 119
Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.
###end article-title 119
###begin article-title 120
###xml 98 101 <span type="species:ncbi:10116">rat</span>
AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.
###end article-title 120
###begin article-title 121
###xml 145 148 <span type="species:ncbi:10116">rat</span>
Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.
###end article-title 121
###begin article-title 122
Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.
###end article-title 122
###begin article-title 123
Ceramide recruits and activates protein kinase C zeta (PKC zeta) within structured membrane microdomains.
###end article-title 123
###begin article-title 124
###xml 36 41 <span type="species:ncbi:9606">human</span>
Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.
###end article-title 124

